Axsome Therapeutics Announces Results of the SUPPORT Survey of Patients with Major Depressive Disorder Presented at the American Society of Clinical Psychopharmacology Association (ASCP) 2022 Annual Meeting - GlobeNewswire

Submitted by Anonymous (not verified) on Mon, 06/06/2022 - 11:00